A detailed history of Ea Series Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ea Series Trust holds 39,579 shares of BMY stock, worth $2.27 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
39,579
Holding current value
$2.27 Million
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$63.71 - $70.74 $2.52 Million - $2.8 Million
39,579 New
39,579 $2.53 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ea Series Trust Portfolio

Follow Ea Series Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ea Series Trust, based on Form 13F filings with the SEC.

News

Stay updated on Ea Series Trust with notifications on news.